文献速递鼻科头颈外科

氨甲环酸在内镜鼻窦与颅底手术中的应用:系统综述与荟萃分析

Tranexamic acid in endoscopic sinus and skull base surgery: A systematic review and meta-analysis.
PubMed 文献 · Int Forum Allergy Rhinol · 2023-06-15

该研究检索多个数据库至2022年9月1日,纳入17项内镜鼻窦手术随机对照试验(n=1377)和1项内镜颅底手术随机对照试验(n=50)。荟萃分析显示,全身或局部氨甲环酸均可改善术野质量并减少术中出血,且未增加围手术期并发症。

要点

  • 全身与局部氨甲环酸均显著改善内镜鼻窦手术术野质量。
  • 全身与局部氨甲环酸均显著减少内镜鼻窦手术术中出血。
  • 氨甲环酸未增加围手术期并发症包括血栓事件。

核心结论

  • 荟萃分析表明,内镜鼻窦手术中使用氨甲环酸可改善术野质量并减少术中出血。
  • 氨甲环酸使用未导致围手术期并发症(包括血栓事件)增加。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、MEDLINE、Embase、Web of Science和Cochrane Library从建库至2022年9月1日。
  • 纳入17项内镜鼻窦手术随机对照试验(n=1377)和1项内镜颅底手术随机对照试验(n=50)。
  • 两名评价者独立筛选文献、提取数据并使用Cochrane随机试验偏倚风险评估工具评价方法学质量。
  • 采用随机效应模型合并数据,连续数据以均数差表示,二分类数据以比值比表示。

主要发现

  • 与对照相比,全身氨甲环酸(6项研究)显著改善术野质量(p < 0.00001)。
  • 与对照相比,局部氨甲环酸(6项研究)显著改善术野质量(p = 0.01)。
  • 与对照相比,全身氨甲环酸(8项研究)和局部氨甲环酸(3项研究)均显著减少术中出血(p < 0.00001)。
  • 手术时间存在显著差异(p < 0.001),但围手术期结局无显著差异(p = 0.30)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endoscopic sinus surgery (ESS) and endoscopic skull base surgery (ESBS) approaches have revolutionized the management of sinonasal and intracranial pathology. Maintaining surgical hemostasis is essential as bleeding can obscure the visibility of the surgical field, thus increasing surgical duration, risk of complications, and procedural failure. Tranexamic acid (TXA) acts to reduce bleeding by inhibiting fibrin degradation. This review aims to assess whether TXA improves surgical field quality and reduces intraoperative blood loss compared with control. METHODS: We searched PubMed, MEDLINE, Embase, Web of Science, and Cochrane Library from inception until September 1, 2022. Two reviewers independently screened citations, extracted data, and assessed methodological quality using the Cochrane risk-of-bias tool for randomized trials. Data were pooled using a random-effect model, with continuous data presented as mean differences and dichotomous data presented as odds ratios. RESULTS: Seventeen ESS randomized controlled trials (n = 1377) and one ESBS randomized controlled trial (n = 50) were reviewed. Significant improvement in surgical field quality was achieved with both systemic TXA (six studies, p < 0.00001) and topical TXA (six studies, p = 0.01) compared with the control. Systemic TXA (eight studies) and topical TXA (three studies) both achieved a significant reduction in intraoperative blood loss compared with the control (p < 0.00001). There were significant differences in operative times (p < 0.001) but no significant difference in perioperative outcomes (p = 0.30). CONCLUSION: This meta-analysis demonstrated that the administration of TXA in ESS can improve surgical field quality and reduce intraoperative blood loss. TXA use did not result in increased perioperative complications including thrombotic events.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Abdallah Z, Staibano P, Zhou K, et al. Tranexamic acid in endoscopic sinus and skull base surgery: A systematic review and meta-analysis. Int Forum Allergy Rhinol. 2023. PMID: 37259887. doi:10.1002/alr.23203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。